Meeting
2017 ASCO Annual Meeting
Molecular analysis of thymic epithelial tumors (TETs): A report by The Cancer Genome Atlas (TCGA) research network.
Authors
Patrick J. Loehrer Sr.
Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN
Patrick J. Loehrer Sr., Anne S. Tsao , Milan Radovich , Ina Felau
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers
Track
Lung Cancer
Sub Track
Local-Regional Non–Small Cell Lung Cancer
Citation
J Clin Oncol 35, 2017 (suppl; abstr 8520)
DOI
10.1200/JCO.2017.35.15_suppl.8520
Abstract #
8520
Poster Bd #
256
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Clinicogenomic characterization of metastatic thymic epithelial tumors.
First Author: Fatemeh Ardeshir-Larijani
Poster
2022 ASCO Annual Meeting
Lenvatinib for the treatment of thymic epithelial tumors (TETs): A real-life multicenter experience.
First Author: Jose Carlos Benitez
Poster
2021 ASCO Annual Meeting
Cell-free circulating tumor DNA (cfDNA) analysis of advanced thymic epithelial tumors (TETs).
First Author: Hiba I. Dada
Poster
2020 ASCO Virtual Scientific Program
Low-dose oral etoposide is an active option for patients with heavily pre-treated thymic epithelial tumors.
First Author: Margaret Ottaviano